Literature DB >> 10051493

Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.

T R Frieden1, L Ozick, C McCord, O V Nainan, S Workman, G Comer, T P Lee, K S Byun, D Patel, K J Henning.   

Abstract

For reasons not yet determined, chronic liver disease (CLD) has been a leading cause of excess morbidity and mortality in central Harlem. We conducted a case series and case-control analysis of demographic, clinical, epidemiological, and alcohol-intake-related information from patients with CLD and age- and sex-matched hospitalized control patients. Patients' sera were tested for markers of viral hepatitis. The presumed etiology of CLD among case-patients was as follows: both alcohol abuse and hepatitis C virus (HCV) infection, 24 persons (46% of case-patients); alcohol abuse alone, 15 (29%); HCV infection alone, 6 (12%); both alcohol abuse and chronic hepatitis B virus (HBV) infection, 3 (6%); and 1 each (2%) from: 1) schistosomiasis, 2) sarcoidosis, 3) unknown causes, and 4) alcohol abuse, chronic HBV, and HCV combined. In the case-control analysis, patients who had both alcoholism and either HBV (odds ratio [OR]: 6.3; 95% CI: 0. 5-334) or HCV (OR: 2.9; 95% CI: 1.3-6.2) were at increased risk for CLD, whereas patients who had only one of these three factors were not at increased risk for CLD. Patients who tested positive for the hepatitis G virus (HGV) did not have a significantly increased risk of CLD, and neither severity of CLD nor mortality was greater among these patients. Most patients in central Harlem who had CLD had liver damage from a combination of alcohol abuse and chronic viral hepatitis. Alcohol and hepatitis viruses appear to be synergistically hepatotoxic; this synergy appears to explain both the high rate of CLD in central Harlem and the recent reductions in this rate. Persons at risk for chronic HBV and HCV infection should be counseled about their increased risk of CLD if they consume excessive alcohol. Morbidity and mortality from liver disease could be decreased further by a reduction in alcohol consumption among persons who have chronic HBV and HCV infection, avoidance of needle sharing, and hepatitis B vaccination.

Entities:  

Mesh:

Year:  1999        PMID: 10051493     DOI: 10.1002/hep.510290308

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011.

Authors:  Kate Drezner; Katherine Bornschlegel; Emily McGibbon; Sharon Balter
Journal:  Public Health Rep       Date:  2013 Nov-Dec       Impact factor: 2.792

Review 2.  Update on chronic viral hepatitis.

Authors:  K Walsh; G J Alexander
Journal:  Postgrad Med J       Date:  2001-08       Impact factor: 2.401

3.  Chronic Hepatitis B.

Authors:  Norah A. Terrault
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

4.  Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.

Authors:  T Diaz; D C Des Jarlais; D Vlahov; T E Perlis; V Edwards; S R Friedman; R Rockwell; D Hoover; I T Williams; E R Monterroso
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Chronic Hepatitis B.

Authors:  Stephanie D Straley; Norah A Terrault
Journal:  Curr Treat Options Gastroenterol       Date:  2004-12

6.  Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

Authors:  Ashwin Balagopal; Frances H Philp; Jacquie Astemborski; Timothy M Block; Anand Mehta; Ronald Long; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; David L Thomas; Stuart C Ray
Journal:  Gastroenterology       Date:  2008-03-29       Impact factor: 22.682

7.  Prevalence of hepatitis C infection in New York City, 2004.

Authors:  Katherine Bornschlegel; Magdalena Berger; Renu K Garg; Amado Punsalang; Christy M McKinney; R Charon Gwynn; Lorna E Thorpe
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

Review 8.  Human genes involved in hepatitis B virus infection.

Authors:  Zheng Zeng
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 9.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27

10.  A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population.

Authors:  Zheng Zeng; Li Guan; Ping An; Shan Sun; Stephen J O'Brien; Cheryl A Winkler
Journal:  BMC Infect Dis       Date:  2008-01-02       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.